AtaiBeckley (ATAI) Capital Expenditures (2020 - 2025)
AtaiBeckley (ATAI) posted quarterly Capital Expenditures of $268000.0 for Q1 2025.
Analysis
AtaiBeckley (ATAI) Capital Expenditures (2020 - 2025) Analysis & Trends
AtaiBeckley has reported Capital Expenditures for 6 years, with the latest figure at $396000.0 in Q3 2025.
- Quarterly Capital Expenditures rose 6500.0% year-over-year to $396000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $791000.0 (up 819.77% YoY) and the FY2024 annual result came in at $6000.0, down 98.19% from the prior year.
- Capital Expenditures for Q1 2025 stood at $268000.0.
- Over five years, Capital Expenditures peaked at $459000.0 in Q3 2022 and troughed at -$100000.0 in Q4 2021.
- A 5-year average of $129625.0 and a median of $98000.0 in 2022 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 7700.0% in 2021, down 300.0% in 2021.
- Over 5 years, Capital Expenditures stood at -$100000.0 in 2021, then jumped by 242.0% to $142000.0 in 2022, then sank by 43.66% to $80000.0 in 2023, then plunged by 92.5% to $6000.0 in 2024, then soared by 6500.0% to $396000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $396000.0, $127000.0, and $268000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 396,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 268,000.00 |
| Mar 31, 2025 | 268,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Dec 31, 2022 | 142,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 116,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 305,000.00 |
| Sep 30, 2021 | 352,000.00 |
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 175,000.00 |
| Dec 31, 2020 | 50,000.00 |